Shandong Buchang Pharmaceuticals Co., Ltd. (SHA:603858)
China · Delayed Price · Currency is CNY 17.05
+0.20 (1.19%)
Feb 3, 2026, 11:29 AM CST
SHA:603858 Market Cap
SHA:603858 has a market cap or net worth of 17.77 billion as of February 2, 2026. Its market cap has increased by 6.07% in one year.
Market Cap
17.77B
Enterprise Value
19.54B
Revenue
10.96B
Ranking
n/a
PE Ratio
10,687.88
Stock Price
17.05
Market Cap Chart
Since November 18, 2016, SHA:603858's market cap has decreased from 54.86B to 17.77B, a decrease of -67.61%. That is a compound annual growth rate of -11.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 2, 2026 | 17.77B | 7.74% |
| Dec 31, 2025 | 16.49B | -2.05% |
| Dec 31, 2024 | 16.84B | -10.50% |
| Dec 29, 2023 | 18.81B | -19.04% |
| Dec 30, 2022 | 23.24B | -0.38% |
| Dec 31, 2021 | 23.33B | -8.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 18, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Walvax Biotechnology | 19.61B |
| Betta Pharmaceuticals | 19.23B |
| China Resources Double-Crane Pharmaceutical | 18.95B |
| Tonghua Dongbao Pharmaceutical | 17.59B |
| Shenzhen Kangtai Biological Products | 17.03B |
| Guangdong Zhongsheng Pharmaceutical | 16.28B |
| Fujian Cosunter Pharmaceutical | 16.25B |
| Hybio Pharmaceutical | 16.04B |